目的 观察小凹蛋白-1(Caveolin-1)在人乳腺癌组织中的表达,探讨Caveolin-1的表达与临床病理因素和预后的相关性。方法 运用免疫组织化学方法(Envision染色)和Western印迹法检测168例人乳腺癌及其配对癌旁正常乳腺组织病理标本中Caveolin-1的表达水平,采用Prism 5.0统计软件分析肿瘤组织Caveolin-1与临床病理因素及患者总生存时间的关系。结果 Caveolin-1在人乳腺癌组织中的表达明显低于乳腺纤维素瘤和癌旁正常组织(19.8% vs 53.8% vs 95.0%,P<0.01);随临床分期的递增(P=0.044)、淋巴结转移的出现(P=0.039)以及HER-2表达(P=0.014)的增加,Caveolin-1表达水平逐渐降低,各组间有显著相关性;Caveolin-1表达阳性的乳腺癌患者,术后5年生存率较Caveolin-1表达阴性者高(P=0.018);Caveolin-1的表达与肿瘤直径、患者年龄、组织学分级及ER/PR的表达无显著相关性。结论 Caveolin-1的表达与临床病理因素及预后有一定关系,其在乳腺癌发生、发展中可能起到肿瘤抑制因子的作用。
Abstract
Objective To investigate the correlation between caveolin-1 expression and clinicopathological factors and prognosis in patients with human breast carcinoma. Methods Using immunnohistochemistry to analyze the caveolin-1 expression in 168 patients with human breast carcinoma and adjacent normal breast tissue. The relationship of caveolin-1 expression and clinicopathological factors were analyzed using statistical software Prism 5.0. Results The expression of caveolin-1 in breast carcinoma was significantly lower than that in adjacent normal tissues (P＜0.01).The caveolin-1 expression was significantly correlated with advancing clinical stage(P=0.044),presence of maxillary lymph node matastasis(P=0.039),and the increase of HER-2 positive(P=0.014). The difference between groups was statistically significant (P＜0.01).The patients with breast carcinoma and positive expression of caveolin-1 had a higher five-year survival rate(P=0.018). The expression of caveolin-1 was not correlated with tumor size,age of the patients and histological grade. Conclusions The expression of caveolin-1 may be involved in the occurrence and development process of breast carcinoma.The expression of caveolin-1 has a certain relationship with clinicopathological factors in breast carcinoma. It may play a role of tumor inhibiting factor in breast carcinoma progression.
关键词
乳腺癌 /
Caveolin-1 /
病理 /
免疫组织化学
Key words
breast carcinoma /
caveolin-1 /
pathology /
immunohistochemistry
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Li T,Sotgia F,Vuolo M A, et al. Caveolin-1 mutations in human breast cancer:functional association with estrogen receptor alpha positive status[J].Am J Pathol,2006,168(1):1998-2013.
[2] 回允中(译). 阿克曼外科病理学[M]. 北京:人民卫生出版社,2009:1603-1615.
[3] National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology:breast screening and diagnosis,version.1.2010[M]. Washington:National Comprehensive Cancer Network, Inc, 2009: 3.
[4] Wiechen K, Diatchenko L, Agoulnik A, et al. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene[J]. Am J Pathol, 2001,159(5):1635-1643.
[5] Vihanto M M,Vindisl C,Djonov V,et al. Caveolin-1 is required for signaling and membrane targeting of EphB1 receptor tyrosine kinase[J].J Cell Sci,2006,119(17):2299-2309.
[6] Cantiani L,Manara M C,Zucchini C,et al.Caveolin-1 Reduces Osteosarcoma Metastases by Inhibiting c-Src Activity and Met Signaling[J].Cancer Res,2007,67(16):7675-7685.
[7] Williams T M,Cheung M W,Park D S,et al.Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice[J].Mol Bool Cell,2003,14(3):1027-1042.
[8] 高万峰,杨 光,史昌乾,等.小凹蛋白-1在食管鳞癌中的表达及意义[J].武警医学,2011,22(10):842-845.
[9] Wlliams T M, Lisanti M P. Caveolin-1 in oncogenic transformation,cancer and metastasis[J]. Am J Physiol cell Physiol, 2005, 288(3): C494-506.
[10] Sunaga N,Miyajima K,Suzuki M, et al. Different Roles for Caveolin-1 in the Development of Non-Small Cell Lung Cancer versus Small Cell Lung Cancer[J].Cancer Res,2004,64:4277-4258.
[11] Williams T M, Medina F,Badano I, et al. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo:role of Cav-1 in cell invasiveness and matrix metalloproteinase(MMP-2/9) secretion[J]. J Biol Chem, 2004,279(2):51630-51646.
